DMXU - ETF AI Analysis
Top Page
Xtrackers Bloomberg Developed Markets ex US Equity ETF (DMXU)
Rating:61Neutral
Price Target:―
Positive Factors
Strong Overall Performance
The ETF has shown solid gains over the year so far, with recent one- and three-month returns also trending positively.
Leading Growth Holdings
Top positions like ASML Holding and Tokyo Electron have delivered strong performance, helping drive the fund’s returns.
Low Expense Ratio
The fund charges a relatively low fee, which helps investors keep more of the returns generated by the portfolio.
Negative Factors
Concentration in a Few Countries
A large portion of the portfolio is focused in Japan, France, and the UK, which increases sensitivity to economic or market issues in those regions.
Mixed Performance Among Top Holdings
While several major holdings are performing well, others like AstraZeneca have been weaker, which can drag on overall results.
Moderate Fund Size
With a relatively modest asset base, the ETF may be less liquid than larger funds, which could lead to wider trading spreads for investors.
DMXU vs. SPDR S&P 500 ETF (SPY)
AUM65.63M
RegionDeveloped Markets
Expense Ratio0.03%
Beta0.77
IssuerXtrackers
Inception DateSep 06, 2018
Dividend Yield3.96%
Asset ClassEquity
Index TrackedBloomberg Developed Markets ex US Core Markets Index - USD - Benchmark TR Net
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume25,413
30 Day Avg. Volume6,911
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
46.01Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering620
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DMXU Summary
EASG is the Xtrackers MSCI EAFE ESG Leaders Equity ETF, which follows the MSCI EAFE ESG Leaders index. It invests in large companies from developed markets outside North America, such as Europe, Japan, and Australia, that score well on environmental, social, and governance (ESG) standards. Well-known holdings include ASML Holding and HSBC. Someone might invest in this ETF to diversify their portfolio internationally while focusing on companies that aim to act responsibly and sustainably. A key risk is that the fund can still rise and fall with global stock markets, especially outside the U.S.
How much will it cost me?The Xtrackers MSCI EAFE ESG Leaders Equity ETF (Ticker: EASG) has an expense ratio of 0.14%, meaning you’ll pay $1.40 per year for every $1,000 invested. This is lower than average because it’s passively managed, tracking an index of ESG-focused companies rather than relying on active stock picking.
What would affect this ETF?The EASG ETF could benefit from growing global interest in ESG-focused investments and sustainability trends, as well as potential economic growth in developed markets outside North America. However, it may face challenges from regulatory changes affecting ESG criteria, economic slowdowns in Europe or Asia, or sector-specific risks in industries like financials and technology, which have significant weight in the fund.
DMXU Top 10 Holdings
DMXU leans heavily on global champions outside the U.S., with a clear tilt toward semiconductors and big European financials. Samsung Electronics and SK hynix are the main engines, with chip momentum rising this year even after some choppy stretches, giving the fund a tech-powered backbone. ASML adds another chip gear, though its recent moves have been more mixed. On the financial side, HSBC and Royal Bank of Canada have been steady but not spectacular, while health care names like Roche and Novartis are more subdued, gently tapping the brakes on overall performance. The result is a developed-markets ex-U.S. portfolio driven largely by Asian chips and European blue chips.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Samsung Electronics | 3.58% | $2.34M | ₩10.00T> | 230.73% | ― | |
| ASML Holding NV | 2.66% | $1.74M | €611.79B | 91.13% | 76 Outperform | |
| SK hynix Inc. | 2.44% | $1.60M | ₩10.00T> | 292.76% | ― | |
| HSBC Holdings | 1.24% | $808.67K | £239.17B | 40.44% | 80 Outperform | |
| Roche Holding AG | 1.18% | $770.82K | $344.30B | 21.61% | 73 Outperform | |
| Shell (UK) | 1.14% | $742.48K | £216.18B | 40.71% | 73 Outperform | |
| Novartis AG | 1.05% | $689.09K | CHF218.02B | 13.47% | 80 Outperform | |
| Royal Bank Of Canada | 0.98% | $640.03K | $266.32B | 33.60% | 75 Outperform | |
| AstraZeneca | 0.93% | $607.11K | $246.54B | -6.13% | 80 Outperform | |
| Nestlé SA | 0.92% | $600.84K | CHF195.59B | -0.68% | 71 Outperform |
DMXU Technical Analysis
Negative
―
Price Trends
38.60
Negative
38.28
Negative
37.18
Positive
Market Momentum
-0.38
Positive
39.09
Neutral
51.72
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DMXU, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 37.90, equal to the 50-day MA of 38.60, and equal to the 200-day MA of 37.18, indicating a neutral trend. The MACD of -0.38 indicates Positive momentum. The RSI at 39.09 is Neutral, neither overbought nor oversold. The STOCH value of 51.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DMXU.
DMXU Peer Comparison
Comparison Results
Performance Comparison
DMXU
Xtrackers Bloomberg Developed Markets ex US Equity ETF
37.23
3.80
11.37%
INEQ
Columbia International Equity Income Etf
―
―
―
DEEF
Xtrackers FTSE Developed ex US Multifactor ETF
―
―
―
QLVD
FlexShares Developed Markets ex-US Quality Low Volatility Index Fund
―
―
―
OEFA
O'Shares International Developed Quality Dividend ETF
―
―
―
RWIN
Rayliant NxtGen Multifactor International Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents